British Journal of Cancer - Table of Contents alert Volume 107 Issue 3

TABLE OF CONTENTS Volume 107, Issue 3 (405-584) Published online 24 July 2012 In this issue Editorials Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer presents: Occupational Cancer in Britain Lesley Rushton and Gareth Evans with the British Occupational Cancer Burden Study Group Foreword by Kurt Straif This study aims to provide an objective estimate of the burden of cancer in Britain due to occupation. It presents extensive analyses for all carcinogens and occupational circumstances defined as relevant by IARC. The results should help the development of an evidence-based approach for occupational cancer control. Read the articles for FREE   Editorials Top Traditional Chinese medicine for cancer? E Ernst Br J Cancer 2012 107: 405; 10.1038/bjc.2012.282 Full Text That the effects of smoking should be measured in pack-years: misconceptions 4 J Peto Br J Cancer 2012 107: 406-407; 10.1038/bjc.2012.97 Abstract | Full Text That recognised risk factors can explain past and present international differences in breast cancer incidence: misconceptions 5 R N Hoover Br J Cancer 2012 107: 408-410; 10.1038/bjc.2012.134 Abstract | Full Text Clinical Studies Top Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas Z Meng, C R Garrett, Y Shen, L Liu, P Yang, Y Huo, Q Zhao, A R Spelman, C S Ng, D Z Chang and L Cohen Br J Cancer 2012 107: 411-416; advance online publication, July 10, 2012; 10.1038/bjc.2012.283 Abstract | Full Text Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme M D Gill, M G Bramble, C J Rees, T J W Lee, D M Bradburn and S J Mills Br J Cancer 2012 107: 417-421; advance online publication, July 10, 2012; 10.1038/bjc.2012.305 Abstract | Full Text Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis B Weide, M Elsässer, P Büttner, A Pflugfelder, U Leiter, T K Eigentler, J Bauer, M Witte, F Meier and C Garbe Br J Cancer 2012 107: 422-428; advance online publication, July 10, 2012; 10.1038/bjc.2012.306 Abstract | Full Text Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours T Doi, A Ohtsu, T Yoshino, N Boku, Y Onozawa, A Fukutomi, S Hironaka, W Koizumi and T Sasaki Br J Cancer 2012 107: 429-434; advance online publication, June 26, 2012; 10.1038/bjc.2012.274 Abstract | Full Text Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study A Roy, D Cunningham, R Hawkins, H Sörbye, A Adenis, J-R Barcelo, G Lopez-Vivanco, G Adler, J-L Canon, F Lofts, C Castanon, E Fonseca, O Rixe, J Aparicio, J Cassinello, M Nicolson, M Mousseau, A Schalhorn, L D'Hondt, J Kerger, D K Hossfeld, C Garcia Giron, R Rodriguez, P Schoffski and J-L Misset Br J Cancer 2012 107: 435-441; advance online publication, July 5, 2012; 10.1038/bjc.2012.286 Abstract | Full Text Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group Ø Fløtten, B H Grønberg, R Bremnes, T Amundsen, S Sundstrøm, H Rolke, K Hornslien, T Wentzel-Larsen, U Aasebø and C von Plessen Br J Cancer 2012 107: 442-447; advance online publication, July 3, 2012; 10.1038/bjc.2012.284 Abstract | Full Text Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers M Takakura, S Kyo, M Nakamura, Y Maida, Y Mizumoto, Y Bono, X Zhang, Y Hashimoto, Y Urata, T Fujiwara and M Inoue Br J Cancer 2012 107: 448-454; advance online publication, June 26, 2012; 10.1038/bjc.2012.276 Abstract | Full Text Sorafenib in advanced melanoma: a critical role for pharmacokinetics? N Pécuchet, C Lebbe, O Mir, B Billemont, B Blanchet, N Franck, M Viguier, R Coriat, M Tod, M-F Avril and F Goldwasser Br J Cancer 2012 107: 455-461; advance online publication, July 5, 2012; 10.1038/bjc.2012.287 Abstract | Full Text Translational Therapeutics Top Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin S G M Piccirillo, S Dietz, B Madhu, J Griffiths, S J Price, V P Collins and C Watts Br J Cancer 2012 107: 462-468; advance online publication, June 21, 2012; 10.1038/bjc.2012.271 Abstract | Full Text Microbubble and ultrasound radioenhancement of bladder cancer W T Tran, S Iradji, E Sofroni, A Giles, D Eddy and G J Czarnota Br J Cancer 2012 107: 469-476; advance online publication, July 12, 2012; 10.1038/bjc.2012.279 Abstract | Full Text Molecular Diagnostics Top Fetal haemopoiesis marking low-grade urinary bladder cancer M Wolk and J E Martin Br J Cancer 2012 107: 477-481; advance online publication, June 26, 2012; 10.1038/bjc.2012.268 Abstract | Full Text Different cellular p16INK4a localisation may signal different survival outcomes in head and neck cancer N Zhao, M-K Ang, X-Y Yin, M R Patel, K Fritchie, L Thorne, K L Muldrew, M C Hayward, W Sun, M D Wilkerson, B S Chera, T Hackman, A M Zanation, J E Grilley-Olson, M E Couch, W W Shockley, M C Weissler, C G Shores, W K Funkhouser, A F Olshan and D N Hayes Br J Cancer 2012 107: 482-490; advance online publication, June 26, 2012; 10.1038/bjc.2012.264 Abstract | Full Text PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma L Brault, T Menter, E C Obermann, S Knapp, S Thommen, J Schwaller and A Tzankov Br J Cancer 2012 107: 491-500; advance online publication, June 21, 2012; 10.1038/bjc.2012.272 Abstract | Full Text Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation A Sadanandam, S S Sidhu, S Wullschleger, S Singh, M L Varney, C-S Yang, A E Ashour, S K Batra and R K Singh Br J Cancer 2012 107: 501-507; advance online publication, July 10, 2012; 10.1038/bjc.2012.298 Abstract | Full Text Independent and functional validation of a multi-tumour-type proliferation signature M H W Starmans, N G Lieuwes, P N Span, S Haider, L Dubois, F Nguyen, H W van Laarhoven, F C G J Sweep, B G Wouters, P C Boutros and P Lambin Br J Cancer 2012 107: 508-515; advance online publication, June 21, 2012; 10.1038/bjc.2012.269 Abstract | Full Text TIGAR induces p53-mediated cell-cycle arrest by regulation of RB–E2F1 complex E Madan, R Gogna, P Kuppusamy, M Bhatt, U Pati and A A Mahdi Br J Cancer 2012 107: 516-526; advance online publication, July 10, 2012; 10.1038/bjc.2012.260 Abstract | Full Text Epidemiology Top A short-term increase in cancer risk associated with daytime napping is likely to reflect pre-clinical disease: prospective cohort study B J Cairns, R C Travis, X-S Wang, G K Reeves, J Green and V Beral on behalf of the Million Women Study Collaborators1 Br J Cancer 2012 107: 527-530; advance online publication, July 10, 2012; 10.1038/bjc.2012.291 Abstract | Full Text Long-term survival after treatment for Hodgkin’s disease (1973–2002): improved survival with successive 10-year cohorts E M Bessell, G Bouliotis, S Armstrong, J Baddeley, A P Haynes, S O'Connor, H Nicholls-Elliott and M Bradley Br J Cancer 2012 107: 531-536; advance online publication, June 19, 2012; 10.1038/bjc.2012.228 Abstract | Full Text Prediagnosis lifestyle exposures and survival of gastric cancer patients: a cohort study from Portugal I Ferronha, C Castro, H Carreira, M J Bento, I Carvalho, B Peleteiro and N Lunet Br J Cancer 2012 107: 537-543; advance online publication, June 14, 2012; 10.1038/bjc.2012.258 Abstract | Full Text Antenatal maternal bereavement and childhood cancer in the offspring: a population-based cohort study in 6 million children J Li, M Vestergaard, C Obel, S Cnattingus, M Gissler, J Ahrensberg and J Olsen Br J Cancer 2012 107: 544-548; advance online publication, July 3, 2012; 10.1038/bjc.2012.288 Abstract | Full Text Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer A B G Kwast, L Liu, J A Roukema, A C Voogd, J J Jobsen, J W Coebergh, I Soerjomataram and S Siesling Br J Cancer 2012 107: 549-555; advance online publication, June 19, 2012; 10.1038/bjc.2012.270 Abstract | Full Text Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d’Ivoire, 2010 A Jaquet, A Horo, V Charbonneau, D K Ekouevi, L Roncin, B Toure, P Coffie, A Minga, A J Sasco, I Garrigue, H Fleury and F Dabis for the IeDEA West Africa collaboration Br J Cancer 2012 107: 556-563; advance online publication, July 10, 2012; 10.1038/bjc.2012.299 Abstract | Full Text Reproductive factors and risk of oesophageal cancer, a population-based nested case–control study in Sweden Y Lu and J Lagergren Br J Cancer 2012 107: 564-569; advance online publication, July 5, 2012; 10.1038/bjc.2012.285 Abstract | Full Text Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients S Kruijff, E Bastiaannet, A B Francken, M Schaapveld, M van der Aa and H J Hoekstra Br J Cancer 2012 107: 570-574; advance online publication, June 19, 2012; 10.1038/bjc.2012.255 Abstract | Full Text The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study K Shafique, R Oliphant and D S Morrison Br J Cancer 2012 107: 575-582; advance online publication, July 3, 2012; 10.1038/bjc.2012.289 Abstract | Full Text Letters to the Editor Top Comment on: ‘Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?’ S S Bielack Br J Cancer 2012 107: 583; advance online publication, June 28, 2012; 10.1038/bjc.2012.280 Full Text Reply: Comment on ‘Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?’ J E Davies, S Neidle and D G Taylor Br J Cancer 2012 107: 584; advance online publication, June 28, 2012; 10.1038/bjc.2012.281 Full Text Advertisement Hot off the press!! Did you know this article from British Journal of Cancer recently appeared in the press? Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal) G S Collins and D G Altman Read this article now!   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.